Discrepancy over Suzhou Highfine Biotech's reported profits ...

Moomoo AI Oct 31, 2023 17:28

Discrepancy over Suzhou Highfine Biotech's reported profits and lack of free cashflow over past year raises queries about its earnings power. Despite EPS growth in three years, potential risks and warning signs are noteworthy.

Suzhou Highfine Biotech's (SZSE:301393) Problems Go Beyond Weak Profit

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

884 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4587Followers

0Following

10KVisitors